Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results—Medicare data Findings from this article were presented at the ASCO Breast Symposium, San Francisco, California, September 7-8, 2007.
dc.contributor.author | Friese, Christopher R. | en_US |
dc.contributor.author | Neville, Bridget A. | en_US |
dc.contributor.author | Edge, Stephen B. | en_US |
dc.contributor.author | Hassett, Michael J. | en_US |
dc.contributor.author | Earle, Craig C. | en_US |
dc.date.accessioned | 2009-03-03T20:10:25Z | |
dc.date.available | 2010-04-14T17:40:05Z | en_US |
dc.date.issued | 2009-02-15 | en_US |
dc.identifier.citation | Friese, Christopher R.; Neville, Bridget A.; Edge, Stephen B.; Hassett, Michael J.; Earle, Craig C. (2009). "Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results—Medicare data Findings from this article were presented at the ASCO Breast Symposium, San Francisco, California, September 7-8, 2007. ." Cancer 115(4): 716-724. <http://hdl.handle.net/2027.42/61889> | en_US |
dc.identifier.issn | 0008-543X | en_US |
dc.identifier.issn | 1097-0142 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/61889 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19152430&dopt=citation | en_US |
dc.description.abstract | BACKGROUND: Despite known benefits to needle biopsy for suspicious breast lesions, variability in the use of this technique has been documented in practice. We sought to study the use of needle biopsy and open surgical biopsy in women with breast cancer, predictors of needle biopsy use, and the effect of biopsy choice on overall number of surgical procedures needed to treat breast cancer. METHODS: We analyzed Surveillance, Epidemiology, and End Results (SEER)-Medicare data for 45,542 women diagnosed between 1991 and 1999 with ductal carcinoma in situ and stage I-II breast cancer. By using diagnosis and procedure codes from 3 months before to 6 months after the SEER diagnosis, we classified the initial biopsy as needle or surgical. By using multivariate logistic regression, we identified patient and tumor characteristics associated with needle biopsy use, and estimated the association between initial biopsy type and likelihood for multiple breast surgeries. RESULTS: Needle biopsy was the initial procedure for 11,073 (24.3%) women. In multivariate analyses, needle biopsy use varied significantly by race, year of diagnosis, and tumor size. After controlling for patient and tumor characteristics, needle biopsy use was associated with a reduced likelihood of multiple breast surgeries (odds ratio, 0.35; 95% confidence interval, 0.34-0.37). CONCLUSIONS: Use of needle biopsy as the initial breast cancer procedure was more common among black women and those with larger tumors, and increased significantly over time. Providers should consider needle biopsy when clinically feasible as the initial breast procedure, because it may reduce the number of surgeries needed to treat breast cancer. Cancer 2009. © 2009 American Cancer Society. | en_US |
dc.format.extent | 186333 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results—Medicare data Findings from this article were presented at the ASCO Breast Symposium, San Francisco, California, September 7-8, 2007. | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Nursing Business and Health Systems, University of Michigan School of Nursing, Ann Arbor, Michigan ; Fax: (734) 647-2417 ; AOCN, University of Michigan School of Nursing, 400 North Ingalls, Room 4162, Ann Arbor, MI 48109-5482 | en_US |
dc.contributor.affiliationother | Center for Outcomes and Policy Research, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts | en_US |
dc.contributor.affiliationother | Department of Breast Surgery, Roswell Park Cancer Institute, Buffalo, New York | en_US |
dc.contributor.affiliationother | Center for Outcomes and Policy Research, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts ; Department of Medicine, Harvard Medical School, Boston, Massachusetts | en_US |
dc.contributor.affiliationother | Health Services Research Program, Cancer Care Ontario and the Ontario Institute for Cancer Research, Toronto, Ontario, Canada | en_US |
dc.identifier.pmid | 19152430 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/61889/1/24085_ftp.pdf | |
dc.identifier.doi | 10.1002/cncr.24085 | en_US |
dc.identifier.source | Cancer | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.